430 related articles for article (PubMed ID: 10066642)
1. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis drugs and hepatotoxicity.
Yew WW; Leung CC
Respirology; 2006 Nov; 11(6):699-707. PubMed ID: 17052297
[TBL] [Abstract][Full Text] [Related]
3. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
[TBL] [Abstract][Full Text] [Related]
4. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
[TBL] [Abstract][Full Text] [Related]
5. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
van Hest R; Baars H; Kik S; van Gerven P; Trompenaars MC; Kalisvaart N; Keizer S; Borgdorff M; Mensen M; Cobelens F
Clin Infect Dis; 2004 Aug; 39(4):488-96. PubMed ID: 15356811
[TBL] [Abstract][Full Text] [Related]
7. [Toxicity in the current treatment of pulmonary tuberculosis in children].
Altet Gómez MN; Alcáide Megías J; Boque Genovard MA
An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974
[TBL] [Abstract][Full Text] [Related]
8. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Kajiki A
J Infect Chemother; 2011 Aug; 17(4):530-3. PubMed ID: 21188445
[TBL] [Abstract][Full Text] [Related]
9. From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury.
Usui T; Meng X; Saide K; Farrell J; Thomson P; Whitaker P; Watson J; French NS; Kevin Park B; Naisbitt DJ
Toxicol Sci; 2017 Feb; 155(2):420-431. PubMed ID: 27803386
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor?
Nader LA; de Mattos AA; Picon PD; Bassanesi SL; De Mattos AZ; Pineiro Rodriguez M
Ann Hepatol; 2010; 9(1):70-4. PubMed ID: 20308724
[TBL] [Abstract][Full Text] [Related]
11. [Antitubercular drug-induced liver injuries].
Guo Y; Cui D
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
[No Abstract] [Full Text] [Related]
12. [Surveillance and complications of antituberculosis chemotherapy].
Duroux P
Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
[No Abstract] [Full Text] [Related]
13. Adverse drug reactions in TB therapy: risks and recommendations.
Yoshikawa TT; Nagami PH
Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
[No Abstract] [Full Text] [Related]
14. Isoniazid hepatotoxicity after orthotopic liver transplantation.
Schluger LK; Sheiner PA; Jonas M; Guarrera JV; Fiel IM; Meyers B; Berk PD
Mt Sinai J Med; 1996; 63(5-6):364-9. PubMed ID: 8898542
[TBL] [Abstract][Full Text] [Related]
15. Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs.
Suzuki Y; Miwa S; Shirai M; Ohba H; Murakami M; Fujita K; Suda T; Nakamura H; Hayakawa H; Chida K
Chest; 2008 Nov; 134(5):1027-1032. PubMed ID: 18583516
[TBL] [Abstract][Full Text] [Related]
16. Management of and risk factors related to hepatotoxicity during tuberculosis treatment.
Babalık A; Arda H; Bakırcı N; Ağca S; Oruç K; Kızıltaş S; Cetintaş G; Calışır HC
Tuberk Toraks; 2012; 60(2):136-44. PubMed ID: 22779934
[TBL] [Abstract][Full Text] [Related]
17. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin].
Fardet L; Lalande V; Meyohas MC; Frottier J; Meynard JL
Presse Med; 1999 Nov; 28(37):2037-8. PubMed ID: 10605471
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis.
Warrington RJ; McPhilips-Feener S; Rutherford WJ
Clin Allergy; 1982 May; 12(3):217-22. PubMed ID: 7105389
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
de Souza AF; de Oliveira e Silva A; Baldi J; de Souza TN; Rizzo PM
Arq Gastroenterol; 1996; 33(4):194-200. PubMed ID: 9302332
[TBL] [Abstract][Full Text] [Related]
20. [Fixed drug eruption after taking ethambutol].
Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
